prodchem
Aug 18, 2026
Asia's naphtha-ethylene spread briefly turned positive in early August after sitting negative for months, and propylene prices are expected to climb through the rest of the month on tighter regional production. Both look like recovery signals on the surface. Set against forecasts that the petrochemical industry will not reach satisfactory profitability until the early 2030s, the picture looks considerably less encouraging.
Buyers watching these short-term price movements need a way to separate a genuine turning point from a temporary blip inside a much longer downturn.
A few specific data points are behind the recent optimism.
Asia's naphtha-to-ethylene spread turned positive on 5 and 6 August after remaining negative since 16 June, even as naphtha prices themselves fell sharply on a weekly basis.
Propylene prices are set to rise through August, driven by lower-than-expected third-quarter production across the region rather than a demand surge.
Asian steam cracker operating rates climbed to around 71 percent in June, with further increases expected in July as units returned from maintenance in China and Japan.
Each of these is a real, verifiable movement. None of them, on their own, signals that the broader supply and demand imbalance behind years of weak margins has actually resolved.
Longer-term industry forecasts paint a much more sobering picture than the recent price movements suggest.
Wood Mackenzie's analysis frames the current capacity build-up as likely to slow only after 2026, at which point the industry would pivot toward a demand-led recovery. Even then, that recovery is expected to be prolonged, with the industry not reaching satisfactory profitability levels until sometime in the early 2030s. Further capacity rationalization is expected over the next 12 to 18 months regardless of short-term price movements.
That timeline matters because it reframes recent gains. A positive spread for two days or an August price bump for one product does not undo a structural imbalance that analysts expect to take years to work through.
Regional capacity additions continue even as individual countries pursue rationalization, which is part of why margin recovery keeps getting pushed further out.
Japan plans to shut three additional crackers by 2028, cutting national ethylene capacity by an estimated 20 percent, starting with a Maruzen Petrochemical cracker closure between 2026 and 2027.
South Korea is targeting a 20 to 28 percent reduction in its 13 million metric ton naphtha cracker capacity, concentrated across the Ulsan, Daesan and Yeosu complexes.
New capacity continues arriving on the US Gulf Coast, in the Middle East and across parts of Asia, which offsets much of the rationalization happening elsewhere in the region.
The result is a market where individual countries are shrinking their footprint while global capacity keeps expanding overall, a combination that limits how much any single country's cuts can move regional pricing on their own.
Buyers do not need to choose between believing the recovery signals or the overcapacity warnings. Both can be true at the same time, operating on different timeframes.
Short-term price movements reflect real supply tightness in specific windows, like August's propylene shortfall, and are useful for near-term purchasing decisions.
Structural overcapacity forecasts describe multi-year trends that short-term price spikes do not reverse, even when they persist for several weeks.
A recovering spread or rising spot price is not the same signal as a capacity rationalization announcement, since one reflects current market tightness and the other reflects a genuine reduction in future supply.
Treating a two-day positive spread as evidence the broader downturn has ended would be a mistake. Treating it as noise and ignoring it entirely would also cost buyers a chance to act on genuine near-term tightness.
A few practical habits help separate signal from noise in this kind of market.
Track whether price movements are tied to a specific, named supply event, like the propylene production shortfall, rather than a broad demand recovery story.
Watch capacity rationalization announcements from Japan and South Korea as the more reliable long-term indicators, since they represent committed reductions rather than temporary price swings.
Avoid extending short-term positive spreads into long-term purchasing assumptions, given how quickly the naphtha-ethylene spread reversed after months in negative territory.
Build sourcing plans around the multi-year overcapacity timeline analysts describe, while still taking advantage of short-term tightness windows as they appear.
Recent price movements in Asian cracking economics are real, but they sit inside a much longer story of structural oversupply that analysts do not expect to resolve until the early 2030s. Buyers who treat August's propylene gains and the brief positive spread as tactical opportunities, rather than evidence the broader downturn has ended, will make better decisions than those reading either signal in isolation.
Featured Product
Found this useful?
Continue Reading
Vaccine policy has become a major chemical and pharmaceutical manufacturing story in 2026, joining tariffs and energy disruption among the issues shaping supply chains. The policy shift reaches from vaccine inputs and adjuvants to domestic production strategy and ACIP authority.
Again says its combined platform with Genomatica dramatically compresses the path from de novo pathway design to industrial execution. Here is what the claim actually covers, and what track record backs it up so far
Qore's Eddyville, Iowa facility is the world's largest biobased BDO plant, built on Genomatica's licensed fermentation technology. Here is how it fits into the broader commercial track record now tied to Genomatica's new owner, Again.
